Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Fosfomycin susceptibility among extended-spectrum- -lactamase-producing Escherichia coli in Nottingham, UK

24 Feb 2010

Abstract excerpt

Sir, Extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella spp. have emerged as a significant clinical problem in the UK.1 CTX-M-producing E. coli have become particularly common as a cause of community-acquired urinary tract infection (UTI) in elderly patients. Whilst antibiotic treatment may not be required in cases where asymptomatic bacteriuria has been detected, treatment options for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibiotic Resistance in Bacteria
Share to Nephrotoxicity and Medicinal Plants
Share to Urinary Tract Infections Management

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 20181572
DOI: 10.1093/jac/dkq051

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

Fosfomycin susceptibility among extended-spectrum- -lactamase-producing Escherichia coli in Nottingham, UKPMID 20181572Read ↗

Fosfomycin susceptibility among multidrug-resistant, extended-spectrum beta-lactamase-producing, carbapenem-resistant uropathogensSemantic proximity Read ↗

Extended-spectrum β-lactamase-producing Enterobacteriaceae: in vitro susceptibility to fosfomycin, nitrofurantoin and tigecycline.Semantic proximity Read ↗

Parallel increase in community use of fosfomycin and resistance to fosfomycin in extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli.Semantic proximity Read ↗

Fosfomycin in the treatment of New Delhi Metallo-β-Lactamase-5 (blaNDM-5)-producing Escherichia coli infectionSemantic proximity Read ↗

Experiences in fosfomycin susceptibility testing and resistance mechanism determination in Escherichia coli from urinary tract infections in the UKSemantic proximity Read ↗

Phenotypic and genotypic profiling of fosfomycin susceptibility in urinary pathogens isolated from pregnant women in North India.Semantic proximity Read ↗

The Role of fosA in Challenges with Fosfomycin Susceptibility Testing of Multispecies Klebsiella pneumoniae Carbapenemase-Producing Clinical IsolatesSemantic proximity Read ↗

Occurrence of multidrug resistance to oral antibiotics among Escherichia coli urine isolates from outpatient departments in Germany: extended-spectrum β-lactamases and the role of fosfomycin.Semantic proximity Read ↗

Mutators among CTX-M beta-lactamase-producing Escherichia coli and risk for the emergence of fosfomycin resistance.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.